[HTML][HTML] Comparison of performance and clinical utility of different methods for detecting anti-PLA2R antibody
T Wang, M Wang, W Yu, H Li, Z Zhao, J Shang - Clinica Chimica Acta, 2023 - Elsevier
Objectives This study aimed to compare the performance of enzyme-linked immunosorbent
assay (ELISA) and magnetic particle chemiluminescence immunoassay (MP-CLIA) for …
assay (ELISA) and magnetic particle chemiluminescence immunoassay (MP-CLIA) for …
Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: clinical value assessment
G Cheng, J Liu, A Gilbert, Y Cao, C An, Z Lv, C Wang… - Clinica Chimica …, 2019 - Elsevier
Background Idiopathic membranous nephropathy (IMN) is widely considered as an organ-
specific autoimmune disorder. Implicated in its pathogenesis are the phospholipase A2 …
specific autoimmune disorder. Implicated in its pathogenesis are the phospholipase A2 …
Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy
E Hoxha, I Thiele, G Zahner, U Panzer… - Journal of the …, 2014 - journals.lww.com
Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults,
with an uncertain clinical outcome. The characterization of the phospholipase A 2 receptor …
with an uncertain clinical outcome. The characterization of the phospholipase A 2 receptor …
[HTML][HTML] Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy
E Hoxha, U Kneißler, G Stege, G Zahner, I Thiele… - Kidney international, 2012 - Elsevier
The M-type phospholipase A2 receptor (PLA 2 R) is the major target antigen in idiopathic
membranous nephropathy with detectable autoantibodies in the serum of up to 70% of …
membranous nephropathy with detectable autoantibodies in the serum of up to 70% of …
Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?
O Ragy, V Rautemaa, A Smith, P Brenchley… - PLoS …, 2023 - journals.plos.org
Background Since the emergence of the anti-PLA2R antibody (PLA2R-Ab) test, nephrology
practice has not changed dramatically, with most nephrologists still relying on a kidney …
practice has not changed dramatically, with most nephrologists still relying on a kidney …
Detection of PLA2R autoantibodies before the diagnosis of membranous nephropathy
PD Burbelo, M Joshi, A Chaturvedi… - Journal of the …, 2020 - journals.lww.com
Background Circulating serum autoantibodies against the M-type phospholipase A2
receptor (PLA2R-AB) are a key biomarker in the diagnosis and monitoring of primary …
receptor (PLA2R-AB) are a key biomarker in the diagnosis and monitoring of primary …
Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy …
F Pourcine, K Dahan, F Mihout, M Cachanado… - PloS one, 2017 - journals.plos.org
Introduction Clinical course of membranous nephropathy (MN) is difficult to predict.
Measurement of circulating anti-PLA2R autoantibodies (PLA2R-Ab) and detection in …
Measurement of circulating anti-PLA2R autoantibodies (PLA2R-Ab) and detection in …
Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy
Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome
in native kidney biopsies from adults. In 2009, antibodies to the M-type receptor of …
in native kidney biopsies from adults. In 2009, antibodies to the M-type receptor of …
Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy
M Tampoia, F Migliucci, C Villani, L Abbracciavento… - Journal of …, 2018 - Springer
Autoantibodies against phospholipase A2 receptor (PLA2R) are a sensitive and specific
marker for idiopathic membranous nephropathy (IMN). The aim of our study was to redefine …
marker for idiopathic membranous nephropathy (IMN). The aim of our study was to redefine …
Phospholipase A2 receptor 1 epitope spreading at baseline predicts reduced likelihood of remission of membranous nephropathy
B Seitz-Polski, H Debiec, A Rousseau… - Journal of the …, 2018 - journals.lww.com
The phospholipase A2 receptor (PLA2R1) is the major autoantigen in primary membranous
nephropathy. Several PLA2R1 epitopes have been characterized, and a retrospective study …
nephropathy. Several PLA2R1 epitopes have been characterized, and a retrospective study …